IE
BVS icon

Israel Englander’s Bioventus BVS Stock Holding History

Israel Englander’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$669K – 6028
2025
Q3 		$669K Buy
+100,000
New +$694K ﹤0.01% 4895
2022
Q1 		– Sell
-50,000
Closed -$725K – 6935
2021
Q4 		$725K Buy
+50,000
New +$711K ﹤0.01% 4723

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's BVS Position: Q2 2026 in Review

Israel Englander increased its Bioventus (BVS) stake by 1,124% in Q2 2026, buying an estimated $1.78M and bringing the position to 203,512 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

Israel Englander first reported a position in BVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $33M in Q1 2021. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Israel Englander held 203,512 shares of Bioventus worth $1.92M as of Q2 2026.
  • Israel Englander bought 186,879 Bioventus shares in Q2 2026, an estimated $1.78M.
  • Bioventus made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3852 holding.
  • Israel Englander first reported a position in Bioventus in Q1 2021 and has held it in 21 quarters since.
  • Israel Englander's Bioventus position peaked at $33M in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.